Home Biosimilar Antibodies Others Antibody-Drug Conjugate inhibitor Ladiratuzumab vedotin For research use only.
Not for use in humans.

Ladiratuzumab vedotin

Synonyms: SGN-LIV1A, Anti-LIV-1 ADC

Ladiratuzumab vedotin (SGN-LIV1A, Anti-LIV-1 ADC) is an antibody-drug conjugate (ADC) composed of humanized anti-LIV-1 antibody, conjugated to Monomethyl auristatin E (MMAE), via a proteolytically cleavable type linker. Ladiratuzumab vedotin has the potential for use in multiple carcinomas.

Ladiratuzumab vedotin

CAS No.

Click to purchase the isotype control of Ladiratuzumab vedotin

Purity & Quality Control

Batch: D405701 Purity: 99.15% Protein concentration: 3.21mg/ml Endotoxin Level: ＜1EU/mg
99.15

Choose Selective Antibody-Drug Conjugate Inhibitors

Biological Activity

Description Ladiratuzumab vedotin (SGN-LIV1A, Anti-LIV-1 ADC) is an antibody-drug conjugate (ADC) composed of humanized anti-LIV-1 antibody, conjugated to Monomethyl auristatin E (MMAE), via a proteolytically cleavable type linker. Ladiratuzumab vedotin has the potential for use in multiple carcinomas.

Product Details

DAR 4.16
ADC antiody ladiratuzumab
ADC linker A proteolytically cleavable type linker
ADC cytotoxin MMAE
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ladiratuzumab vedotin | Ladiratuzumab vedotin supplier | purchase Ladiratuzumab vedotin | Ladiratuzumab vedotin cost | Ladiratuzumab vedotin manufacturer | order Ladiratuzumab vedotin | Ladiratuzumab vedotin distributor